Single- and multiple-ascending dose study demonstrates the human pharmacokinetics and tolerability of SPR994 (tebipenem pivoxil hydrobromide), an oral carbapenem, at the predicted therapeutic dose

Single- and multiple-ascending dose study demonstrates the human pharmacokinetics and tolerability of SPR994 (tebipenem pivoxil hydrobromide), an oral carbapenem, at the predicted therapeutic dose